# Peak Bio, Inc.

Peak Bio, Inc. is a company headquartered in Pleasanton, CA, United States.

## Company overview

- **Legal name:** Peak Bio, Inc.
- **Former names in filing history:** Ignyte Acquisition Corp. (2020-12-09 to 2022-11-02)
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Pleasanton, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001834645

## About

Peak Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001834645, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2024-08-06, it reported annual revenue of USD 367,877; net income of USD -12,825,917; total assets of USD 2,596,415 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $367,877 (USD 367,877)
- **Net income:** -$12.8M (USD -12,825,917)
- **Total assets:** $2.6M (USD 2,596,415)
- **Cash and equivalents:** $381,649 (USD 381,649)
- **Operating cash flow:** -$4.8M (USD -4,758,020)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $607,681 (USD 607,681)
- **Net income:** -$13.1M (USD -13,088,717)
- **Total assets:** $7.5M (USD 7,529,712)
- **Cash and equivalents:** $654,892 (USD 654,892)
- **Operating cash flow:** -$7.5M (USD -7,485,625)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2021 (period ended 2021-12-31)

- **Net income:** -$487,989 (USD -487,989)
- **Total assets:** $57.9M (USD 57,906,810)
- **Cash and equivalents:** $329,192 (USD 329,192)
- **Operating cash flow:** -$603,323 (USD -603,323)
- **Later filings:** Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2024-11-14 — period 2024-11-14 — 8-K
- Form 10-Q — filed 2024-11-12 — period 2024-09-30 — 10-Q
- Form 8-K — filed 2024-11-07 — period 2024-11-07 — 8-K
- Form 8-K — filed 2024-09-30 — period 2024-09-24 — 8-K
- Form 8-K — filed 2024-09-03 — period 2024-08-27 — 8-K
- Form 10-Q — filed 2024-08-23 — period 2024-06-30 — 10-Q
- Form 10-Q — filed 2024-08-23 — period 2024-03-31 — 10-Q
- Form 8-K — filed 2024-08-14 — period 2024-08-08 — 8-K
- Form 10-K — filed 2024-08-06 — period 2023-12-31 — 10-K
- Form 8-K — filed 2024-07-24 — period 2024-07-19 — 8-K
- Form 8-K — filed 2024-07-17 — period 2024-07-12 — 8-K
- Form 10-Q — filed 2024-06-25 — period 2023-09-30 — 10-Q

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/peak-bio-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology